Captopril Questioned for Diabetes Patients in COVID-19 Setting Captopril Questioned for Diabetes Patients in COVID-19 Setting

Captopril appears to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than other ACE inhibitors or angiotensin receptor blockers, a new study suggests.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news